Fentanyl Buccal Tablet for Relief of Breakthrough Pain in Opioid-Tolerant Patients With Cancer-Related Chronic Pain

Original research
par
Slatkin, Neal E. et al

Date de publication

2007

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

This study evaluated fentanyl buccal tablets for breakthrough pain in opioid-tolerant patients with chronic cancer pain.

Constatations/points à retenir

FBT was efficacious, well tolerated, demonstrated rapid onset of analgesia (within 10 minutes), and had a sustained effect.

La conception ou méthodologie de recherche

Randomized, double-blind, placebo-controlled design and was conducted at 30 outpatient treatment centers in the United States

Mots clés

About prescribers
Chronic pain